Top Suppliers:I want be here


  • DC Chemicals Limited
  • China
  • Product Name: Asp-3026
  • Price: $400.0/100mg $800.0/250mg $1600.0/1g
  • Purity: 98.0%
  • Stocking Period: 3 Day
  • Contact: Tony Cao

1097917-15-1

1097917-15-1 structure
1097917-15-1 structure
  • Name: ASP3026
  • Chemical Name: 2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]-4-N-(2-propan-2-ylsulfonylphenyl)-1,3,5-triazine-2,4-diamine
  • CAS Number: 1097917-15-1
  • Molecular Formula: C29H40N8O3S
  • Molecular Weight: 580.745
  • Catalog: Biochemical Inhibitor Protein tyrosine kinase
  • Create Date: 2016-09-18 10:15:15
  • Modify Date: 2024-01-02 12:26:26
  • ASP3026 is a novel and selective inhibitor for ALK (anaplastic lymphoma kinase) with IC50 of 3.5 nM.

Name 2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]-4-N-(2-propan-2-ylsulfonylphenyl)-1,3,5-triazine-2,4-diamine
Synonyms N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine
cc-325
QCR-144
N-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}-N'-[2-(propane-2-sulfonyl)phenyl]-1,3,5-triazine-2,4-diamine
ASP 3026
N-[2-(isopropylsulfonyl)phenyl]-N'-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}-1,3,5-triazine-2,4-diamine
1,3,5-Triazine-2,4-diamine, N-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N-[2-[(1-methylethyl)sulfonyl]phenyl]-
CS-0787
UNII-HP4L6MXF10
N-[2-(Isopropylsulfonyl)phenyl]-N'-{2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl}-1,3,5-triazine-2,4-diamine
ASP3026
Description ASP3026 is a novel and selective inhibitor for ALK (anaplastic lymphoma kinase) with IC50 of 3.5 nM.
Related Catalog
References

[1]. Sadao Kuromitsu, et al. AACR 102nd Annual Meeting, 2011.

Density 1.3±0.1 g/cm3
Boiling Point 794.3±70.0 °C at 760 mmHg
Molecular Formula C29H40N8O3S
Molecular Weight 580.745
Flash Point 434.2±35.7 °C
Exact Mass 580.294434
PSA 127.43000
LogP 1.01
Vapour Pressure 0.0±2.8 mmHg at 25°C
Index of Refraction 1.620
Storage condition -20°C

~85%

1097917-15-1 structure

1097917-15-1

Literature: Astellas Pharma Inc.; OBITSU, Kazuyoshi; AKIBA, Takahiro; KOBAYASHI, Koji; HIRASAWA, Shun; KONDOH, Yutaka; TAKEGUCHI, Kazuhiro; TAKAHAMA, Yuji; ORII, Ryoki Patent: EP2669281 A1, 2013 ; Location in patent: Paragraph 0059 ;

~%

1097917-15-1 structure

1097917-15-1

Literature: EP2669281 A1, ;

~%

1097917-15-1 structure

1097917-15-1

Literature: EP2669281 A1, ;

~%

1097917-15-1 structure

1097917-15-1

Literature: EP2669281 A1, ;

~%

1097917-15-1 structure

1097917-15-1

Literature: EP2669281 A1, ;

~%

1097917-15-1 structure

1097917-15-1

Literature: EP2669281 A1, ;

~%

1097917-15-1 structure

1097917-15-1

Literature: EP2669281 A1, ;

~%

1097917-15-1 structure

1097917-15-1

Literature: EP2669281 A1, ;